How do cannabis companies manage reputation in a stigmatized industry?

Cannabis companies carry a reputation problem shaped by stigma and a legal patchwork that varies state by state and conflicts with federal law, so the work is both more constrained and more defensive than in conventional consumer sectors. Content has to be scrupulously regulatory-aware, because the rules differ by jurisdiction and a careless claim invites enforcement on top of reputational harm. Credentialed executive bios reinforce that the company is run by serious people. We monitor AI engine answers across investor and consumer prompts with AIQ™, because the category-level stigma means a model can attach broad negative framing to a specific compliant firm, and investors and consumers now ask models to assess legitimacy. For cannabis, much of the reputation work is establishing that this particular company is the credible, compliant version of a category the public still views with suspicion.